Sonaselection India IPO Details: Price, Dates & Financials
The Sonaselection India IPO is a closed mainboard Bookbuilding offer (Fresh capital only) that opened on 17 September 2026. The Sonaselection India IPO closed on 21 September 2026, with an issue price of ₹99 per share. The Sonaselection India IPO has a face value of ₹10 and a lot size of 150 shares. The Sonaselection India IPO size aggregates up to ₹142 crore, listing on NSE & BSE on 24 September 2026. The Sonaselection India IPO allotment was scheduled for 22 September 2026.
On the financial front, the Sonaselection India IPO reported revenue of ₹518 crore for 31 Mar 2026, compared with ₹316 crore for 31 Mar 2025. The Sonaselection India IPO PAT was ₹34 crore against ₹19 crore. The Sonaselection India IPO EBITDA stood at ₹85 crore with a 16.40% margin. The Sonaselection India IPO net worth as of 31 Mar 2026 was ₹104 crore.
Always verify The Sonaselection India IPO details and GMP data with the official offer document before investing in the Sonaselection India IPO.
Financial Summary
Amount in ₹ Crore
Metric
31 Mar 2026
31 Mar 2025
31 Mar 2024
Total Assets
475
375
204
Revenue
518
316
121
PAT
34
19
13
EBITDA
85
58
28
Net Worth
104
70
39
Reserves
62
47
36
Total Borrowing
258
207
145
Sonaselection India IPO Financials FAQs
Revenue of Sonaselection India (Amount in ₹ Crore) — 31 Mar 2026: 518; 31 Mar 2025: 316; 31 Mar 2024: 121. Profit after tax (PAT) — 31 Mar 2026: 34; 31 Mar 2025: 19; 31 Mar 2024: 13.
EBITDA of Sonaselection India (Amount in ₹ Crore) — 31 Mar 2026: 85; 31 Mar 2025: 58; 31 Mar 2024: 28. The EBITDA margin is 16.40%.
Total assets — 31 Mar 2026: 475; 31 Mar 2025: 375; 31 Mar 2024: 204. Net worth — 31 Mar 2026: 104; 31 Mar 2025: 70; 31 Mar 2024: 39. Reserves & surplus — 31 Mar 2026: 62; 31 Mar 2025: 47; 31 Mar 2024: 36. (Amount in ₹ Crore)
Total borrowing of Sonaselection India (Amount in ₹ Crore) — 31 Mar 2026: 258; 31 Mar 2025: 207; 31 Mar 2024: 145. Debt-to-equity ratio: 2.48.
The financials shown for Sonaselection India IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
